Prosperity Wealth Management Inc. Acquires 8,399 Shares of Oscar Health, Inc. (NYSE:OSCR)

Prosperity Wealth Management Inc. grew its holdings in Oscar Health, Inc. (NYSE:OSCRFree Report) by 10.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 87,676 shares of the company’s stock after purchasing an additional 8,399 shares during the quarter. Prosperity Wealth Management Inc.’s holdings in Oscar Health were worth $1,149,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of OSCR. JPMorgan Chase & Co. raised its holdings in shares of Oscar Health by 348.7% in the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company’s stock valued at $139,246,000 after purchasing an additional 8,051,379 shares in the last quarter. BIT Capital GmbH raised its holdings in shares of Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company’s stock valued at $60,129,000 after purchasing an additional 4,396,872 shares in the last quarter. Deerfield Management Company L.P. Series C raised its holdings in shares of Oscar Health by 50.7% in the 4th quarter. Deerfield Management Company L.P. Series C now owns 11,835,000 shares of the company’s stock valued at $159,062,000 after purchasing an additional 3,983,325 shares in the last quarter. Gilder Gagnon Howe & Co. LLC raised its stake in shares of Oscar Health by 51.4% during the 4th quarter. Gilder Gagnon Howe & Co. LLC now owns 6,335,862 shares of the company’s stock worth $85,154,000 after acquiring an additional 2,151,256 shares in the last quarter. Finally, Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Analyst Ratings Changes

OSCR has been the subject of several recent analyst reports. Wall Street Zen lowered shares of Oscar Health from a “buy” rating to a “hold” rating in a research note on Sunday, June 8th. Wells Fargo & Company lowered shares of Oscar Health from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Finally, Piper Sandler reduced their price objective on shares of Oscar Health from $25.00 to $18.00 and set an “overweight” rating for the company in a research note on Monday, June 9th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Oscar Health currently has a consensus rating of “Hold” and a consensus target price of $16.50.

Get Our Latest Stock Analysis on Oscar Health

Oscar Health Trading Up 7.7%

Shares of Oscar Health stock opened at $16.10 on Wednesday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.22. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The firm has a market capitalization of $4.10 billion, a price-to-earnings ratio of 57.50 and a beta of 1.73. The firm’s 50 day simple moving average is $14.16 and its two-hundred day simple moving average is $14.45.

Oscar Health (NYSE:OSCRGet Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 1.22% and a return on equity of 10.59%. The business had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same quarter in the prior year, the business posted $0.62 EPS. Oscar Health’s revenue for the quarter was up 42.2% compared to the same quarter last year. Analysts predict that Oscar Health, Inc. will post 0.69 EPS for the current year.

Insider Buying and Selling at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company’s stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total value of $410,750.00. Following the sale, the director now directly owns 64,512 shares of the company’s stock, valued at $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 25.11% of the stock is currently owned by company insiders.

Oscar Health Company Profile

(Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

See Also

Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCRFree Report).

Institutional Ownership by Quarter for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.